CYCLOPENTYL TACHYKININ RECEPTOR ANTAGONISTS

The present invention is directed to certain novel compounds represented by structural formula (I) or a pharmaceutically acceptable salt thereof, wherein R , R , R , R , R , R , R , A, Q, W, X, Y, Z and n are defined herein. The invention is also concerned with pharmaceutical formulations comprising...

Full description

Saved in:
Bibliographic Details
Main Authors KOPKA, IHOR, FINKE, PAUL, E, CALDWELL, CHARLES, G, ROBICHAUD, ALBERT, MACCOSS, MALCOM, CHEN, PING, HOLSON, EDWARD, MILLS, SANDER, G, DURETTE, PHILIPPE, L, HALE, JEFFERY, MEURER, LAURA, C
Format Patent
LanguageEnglish
French
Published 24.04.1997
Edition6
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention is directed to certain novel compounds represented by structural formula (I) or a pharmaceutically acceptable salt thereof, wherein R , R , R , R , R , R , R , A, Q, W, X, Y, Z and n are defined herein. The invention is also concerned with pharmaceutical formulations comprising these novel compounds as active ingredients and the use of the novel compounds and their formulation in the treatment of certain disorders. The compounds of this invention are tachykinin receptor antagonists and are useful in the treatment of inflammatory diseases, pain or migraine, asthma and emesis. L'invention concerne de nouveaux composés représentés par la formule développée (I) ou leurs sels pharmaceutiquement acceptables. Dans ladite formule, R , R , R , R , R , R , R , A, Q, W, X, Y, Z et n correspondent à la définition donnée dans la description. L'invention concerne également des formulations pharmaceutiques comportant comme ingrédients actifs ces composés, ainsi que l'utilisation de ces composés et de leurs formulations dans le traitement de certains troubles. Les composés selon l'invention sont des antagonistes des récepteurs des tachykinines et sont utiles dans le traitement des maladies inflammatoires, des douleurs et des migraines, de l'asthme et des vomissements.
Bibliography:Application Number: WO1996US16489